Drugs & Pharmaceuticals

News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.

Our resident chemist, Dr. Josh Bloom, has followed the opioid crisis for several years. He was the first to raise the alarm that opioid overdoses and deaths were being driven largely by fentanyl, not Vicodin or other prescription pills.
In any normal year, an academic debate about the efficacy of a certain drug to treat an infection would never garner media attention. But this isn't a normal year.
“The initiative — to accelerate the development of Covid-19 vaccines and therapeutics — lacks the scale, and the degree of secrecy, of the effort to build the atomic bomb.
Anyone in the mood for some confusion? If so, keep reading. Below are some random quotes I stumbled across while doing a Google news search of the term "synthetic opioids." It didn't take long.
Doctors and scientists are throwing every conceivable size, shape, and color of the kitchen sink at COVID (as well they should) but there is little to show for it so far.
This article was originally published at Geopolitical Futures. The original is here.
I recently received a notification from John Rex and Kevin Outterson regarding the fact that many recently appr
It is difficult to overstate the potential damage that a rushed coronavirus vaccine could inflict on confidence in the biomedical community.
There are several coronavirus vaccines that are currently in Phase 3 clinical trials. For vaccines, this final experimental stage requires tens of thousands of people in order to properly assess efficacy and safety.
Several months ago, we were about to cover an important story out of San Francisco. However, the coronavirus pandemic hit, and we've been focused almost exclusively on it since then.